CXCL9 and hepatocellular carcinoma: Thirdly, although the CXCL9-CXCR3 axis is known to play a role in recruiting immune cells, specifically cytotoxic T lymphocytes and macrophages [31], the current multiplexed panel design for the HCC cohort includes CD68 but lacks additional confirmatory macrophage markers.